Qualcomm Collaborates With LitePoint to Test its 5G RAN Platform for Small Cells

0
158

The Qualcomm 5G RAN Platform for Small Cells (FSM 100xx) is the industry’s first 5G NR solution for small cells

Qualcomm Technologies is partnering with wireless test solutions firm LitePoint for testing the Qualcomm 5G RAN Platform for Small Cells (FSM 100xx) to accelerate small cell deployment, LitePoint said in an official statement. 

Small cells are crucial for mobile operator 5G network deployments, as they are designed to provide increased coverage and uniform 5G user experiences while delivering high data rate and low latencies. 

Specifically, 5G small cells offer superior power consumption and performance while enabling greater coverage and throughput in high-density, metropolitan areas and growing, indoor enterprise environments

“This 5G small cell engagement is built on longstanding, trusted and successful cooperation between the companies for many years and leverages their in-depth expertise to enable 5G small cells,” said Rex Chen, Director of Strategic Business Development at LitePoint.

The Qualcomm 5G RAN Platform for Small Cells (FSM 100xx) is the industry’s first 5G NR solution for small cells. This platform is designed to support original equipment manufacturers (OEMs) to reuse both software and hardware designs across sub-6GHz and mmWave products. 

“We are pleased to be working with LitePoint to support the rapidly growing 5G industry with enhanced mobile broadband connectivity by improving network coverage, capacity, performance and power efficiency through our advanced 5G RAN solutions,” said Victor Abramsky, vice president, engineering, Qualcomm Technologies, Inc.

“By working with industry-leaders like LitePoint, we can accelerate the deployment of 5G small cells globally by providing customers with advanced 5G technologies.”

LitePoint offers its 5G test solutions to address the emerging 5G small cell market and accelerating 5G deployments in outdoor metropolitan and indoor enterprise locations. 

SHARE YOUR THOUGHTS & COMMENTS

Please enter your comment!
Please enter your name here

Are you human? *